Streetbeat News

Analyst Ratings

U

Needham analyst Bernie McTernan has maintained a 'Buy' rating on Unity Software (NYSE:U) but lowered the price target from $50 to $40.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 1:08 pm

WEST

Telsey Advisory Group analyst Sarang Vora has maintained an 'Outperform' rating on Westrock Coffee (NASDAQ:WEST) but lowered the price target from $14 to $11.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 1:06 pm

VIR

Vir Biotechnology (NASDAQ:VIR) will present new data from its Phase 2 trials evaluating VIR-3434 and VIR-2218 for chronic hepatitis B and delta at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting in November 2023. The company will host an investor conference call to discuss the data on November 13th. VIR-3434 and VIR-2218 are investigational treatments designed to block entry of hepatitis B and delta viruses into hepatocytes and reduce the level of virions and subviral particles in the blood.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 1:06 pm

BHC

Bausch Health Companies Inc. (NYSE:BHC) and its gastroenterology business, Salix Pharmaceuticals, have announced findings from a descriptive analysis of a hospital database showing that the absence of an overt hepatic encephalopathy-specific diagnosis code may have resulted in increased length of stay and hospitalization-related costs. The analysis showed that hospitalizations identified using in-hospital Xifaxan or lactulose use combined with a diagnosis for altered mental status, unspecified encephalopathy, or cirrhosis, had a mean hospital billing charge 2.5 times higher and mean length of stay 2.0 times longer than solely relying on OHE as a primary diagnosis.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 1:05 pm

VALN

HC Wainwright & Co. analyst Edward White maintains a 'Buy' rating on Valneva (NASDAQ:VALN) and raises the price target from $22 to $26.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 1:05 pm

HE

ILMN

PLUG

TLS

TWOU

VERA

Top Wall Street analysts have updated their outlooks on several stocks. Telos Corporation (TLS) and Vera Therapeutics, Inc. (VERA) were upgraded to Buy, while Hawaiian Electric Industries, Inc. (HE), 2U, Inc. (TWOU), Plug Power Inc. (PLUG), and Illumina, Inc. (ILMN) were downgraded. Price targets were raised for TLS, HE, VERA, Vertex, Inc. (VERX), and Synaptics Incorporated (SYNA), but lowered for TWOU, PLUG, Unity Software Inc. (U), Target Corporation (TGT), and ILMN.

Portfolio Pulse from Lisa Levin

November 10, 2023 | 1:04 pm

SYNA

Needham analyst Rajvindra Gill maintains a 'Buy' rating on Synaptics (NASDAQ:SYNA) and raises the price target from $100 to $115.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 1:03 pm

SYNA

Over the past 3 months, 6 analysts have given their opinion on Synaptics (NASDAQ:SYNA) stock. The average price target is $109.17, implying an upside from the current price of $96.0. The average price target has increased by 1.55% over the past month. The majority of the ratings are bullish.

Portfolio Pulse from Benzinga Insights

November 10, 2023 | 1:00 pm

LUV

Over the past 3 months, 11 analysts have published their opinion on Southwest Airlines (NYSE:LUV) stock. The average price target is $30.43, implying an upside from the current price of $23.07. However, this average has decreased by 10.5% from the previous average price target of $34.00.

Portfolio Pulse from Benzinga Insights

November 10, 2023 | 1:00 pm

TGT

Over the past 3 months, 31 analysts have published their opinion on Target (NYSE:TGT) stock. The company has an average price target of $148.55, representing a 6.55% decrease from the previous average price target of $158.96. The majority of analysts are indifferent about the stock, with 6 bullish, 6 somewhat bullish, and 19 indifferent ratings.

Portfolio Pulse from Benzinga Insights

November 10, 2023 | 1:00 pm